Introduction:

Pancreatic cystic neoplasms (PCN) are the only known precursor lesions for pancreatic adenocarcinoma. Endoscopic ultrasound (EUS) is considered the gold standard for pancreatic imaging; Intracystic glucose levels less than 50 mg/dL are found in mucin-producing lesions. The S (95%) and E (57%).

Objective:

Determine the effectiveness of glucose in fluid of pancreatic cystic neoplasms.

Method:

Prospective, cross-sectional and observational study where glucose measurement in NQP is determined.

Results:

The information of 35 patients was evaluated. Glucose measurement by glucometry was less than 50 mg/dl in 88.8% of patients with mucinous neoplasms with averages of 22 mg/dl. Glucose < 50 mg/dl with the rope sign had a sensitivity of 93% and a specificity of 68%.

Conclusions:

The glucometry glucose test is rapid and economical and requires minimal cyst fluid, with high sensitivity to differentiate mucinous lesions from serous lesions.

        · resumen en Español     · texto en Español     · Español ( pdf )